(1) Department of Immunology, The Weizmann Institute of Science, Rehovot, 76100, Israel;(2) Department of Organic Chemistry, The Weizmann Institute of Science, Rehovot, 76100, Israel
Abstract:
Cytotoxic T-lymphocytes (CTLs) kill abnormal cells. CTLs recognize major histocompatibility complex class I molecules in complex with peptides derived from relevant antigens. The identification of tumor associated antigen peptides enabled the design of anti-tumor and anti-metastatic vaccines in a murine lung carcinoma.